News
HIMS
15.47
-1.72%
-0.27
Hims & Hers Health, Inc.'s (NYSE:HIMS) institutional investors lost 4.5% last week but have benefitted from longer-term gains
Institutional investors own 54% of Hims & Hers Health, Inc. (NYSE:HIMS) The company has a market capitalization of US$3.4b. 50% of the business is held by the top 14 shareholders of the company. The company is owned by institutions and hedge funds. It is worth looking at the company's ownership of shares to see how insiders are influencing the stock.
Simply Wall St · 1d ago
Analysts Offer Insights on Healthcare Companies: Regulus (RGLS), Hims & Hers Health (HIMS) and Olink Holding (OLK)
TipRanks · 2d ago
Weekly Report: what happened at HIMS last week (0318-0322)?
Weekly Report · 4d ago
Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
telehealth company Hims & Hers Health, Inc. Has been one of the best-performing growth stocks since its bottom in 2022. HIMS has a 465% return since its 2022 bottom and a 63% return year-to-date. The company was caught up in the 2021 bubble and is a great long-term growth stock for the long term. The most important driver for a growth stock is consistency of revenue growth.
Seeking Alpha · 03/21 15:33
After Doubling in the Past 6 Months, Will Hims & Hers Health Stock Continue Higher?
Hims & Hers Health Inc. Has more than tripled in value over the past two years. The telehealth company is a San Francisco-based company selling prescription and over-the-counter drugs. Shares of HIMS have spiked nearly 145% in the past six months. The company's stock is up to a new 52-week high.
Barchart · 03/18 13:30
Weekly Report: what happened at HIMS last week (0311-0315)?
Weekly Report · 03/18 09:05
Hims & Hers Health: A Lesson In Psychology
Hims & Hers Health (HIMS) is a telehealth company that primarily targets Millennials and Gen Z. The company was born out of necessity to provide digital healthcare solutions to the aging population. The stock's success is a lesson in psychology, not fundamentals. Hims and Hers Health's guidance for the next 10 years is overly conservative.
Seeking Alpha · 03/18 06:21
Looking Into Hims & Hers Health's Recent Short Interest
Hims & Hers Health's short percent of float has fallen 7.97% since its last report. The company has 13.47 million shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company and hopes the price will fall.
Benzinga · 03/14 13:30
Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Seeking Alpha · 03/12 20:33
July 2025 Options Now Available For Hims & Hers Health (HIMS)
NASDAQ · 03/11 15:46
Weekly Report: what happened at HIMS last week (0304-0308)?
Weekly Report · 03/11 09:05
What Makes Hims & Hers Health, Inc. (HIMS) a Strong Momentum Stock: Buy Now?
NASDAQ · 03/05 17:00
U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Bark, Fleetcor Technologies and Tesla are among the companies. The analysts raised their ratings on Bark and raised their targets for Fleetcor and Tesla. The companies are all listed on the New York Stock Exchange.
Reuters · 03/05 06:57
LQR, BYND among consumer staples movers
Seeking Alpha · 03/04 15:57
Weekly Report: what happened at HIMS last week (0226-0301)?
Weekly Report · 03/04 09:05
Hims & Hers Health Surges 30% After Earnings. Here Is Why the Stock Is Still a Magnificent Buy.
Shares of direct-to-consumer telehealth business Hims & Hers Health are up 30% this year. The company is a $2 billion company that works directly with patients. Hims and Hers has been putting up impressive growth since going public in 2021. The stock is still a magnificent buy for long-term investors.
The Motley Fool · 03/03 13:20
Maize and Blue Stock Pitch Competition 2024 Showcases Analytical Excellence With Surprising Results, Including A Bearish Call
The Ross School of Business at the University of Michigan hosted the expanded Maize and Blue Stock Pitch Competition on Feb. 9. The competition expanded to allow students from different disciplines to compete. There were eight final contestants, an increase from the previous year. The university's competition required presentations on publicly traded companies.
Benzinga · 02/29 22:21
Hims & Hers Health: A Strong Buy on Accelerated Growth and Market Positioning
TipRanks · 02/29 20:55
3 Telehealth Stocks With Room to Run in 2024
NASDAQ · 02/29 18:53
Why Hims & Hers Health, Inc. (HIMS) Might be Well Poised for a Surge
NASDAQ · 02/29 17:20
More
Webull provides a variety of real-time HIMS stock news. You can receive the latest news about Hims & Hers Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About HIMS
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.